Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
199.70    -2.90 (-1.43%)
Bid:
199.50
Ask:
199.80
Spread: 0.30 (0.15%)
Market Cap: £1.30b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Q2 AuM Statement

13 Jan 2015 07:00

RNS Number : 9910B
Ashmore Group PLC
13 January 2015
Β 

ο»Ώ

Ashmore Group plc

+0700 13 January, 2015

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces today the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2014.

Assets under Management

Theme

Actual30 September 2014

(US$ billion)

Estimated31 December 2014

(US$ billion)

Movement

Q2 vs Q1(%)

External debt

13.3

12.4

-6.8

Local currency

17.1

15.7

-8.2

Corporate debt

7.9

7.4

-6.3

Blended debt

20.7

18.0

-13.0

Equities

5.2

4.3

-17.3

Alternatives

2.2

1.3

-41.0

Multi-strategy

2.2

2.0

-9.1

Overlay / liquidity

2.7

2.6

-3.7

Total

71.3

63.7

-10.7

Β 

Assets under management declined during the quarter to US$63.7 billion as a result of negative investment performance of US$2.8 billion, net outflows of US$4.2 billion and the disposal of the Group's interest in a Chinese real estate joint venture that reduced alternatives AuM by US$0.6 billion.

Investment performance predominantly reflects the sharp sell-off in markets in early December that particularly affected local currency markets. Performance was therefore weakest in the local currency and blended debt themes, with the latter having an allocation to local currency assets. External debt, corporate debt and multi-strategy also saw negative investment performance. Equities, alternatives and overlay/liquidity were flat.

Net outflows in the blended debt theme resulted from a small number of segregated accounts and net outflows were also experienced in equities, external debt and, to a lesser extent, in local currency, multi-strategy, corporate debt and overlay / liquidity. Capital was returned as planned to investors in the alternatives theme.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Weaker commodity prices, US dollar strength and increased price volatility impacted upon Emerging Markets during the quarter, although the diverse range of return opportunities in the asset class continued to show through. While asset prices have fallen, uncertainty over the timing and pace of Federal Reserve rate increases is likely to weigh on sentiment in the near term. However, Emerging Markets' fundamentals remain sound and previous uncertainties, such as election cycles, have abated. Therefore, as is typically the case following a sharp and widespread fall in asset prices, Emerging Markets provide very attractive near-term return opportunities, particularly in blended debt, local currency and equities, for Ashmore's investment processes to capture on behalf of clients."

Β 

Notes:

1. For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.5577 at 31 December 2014 (30 June 2014: 1.7106). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the first half of the year was 1.6289 (H1 2013/14: 1.5868).

2. The Group's share of profits or losses from the Chinese real estate joint venture is recognised in the consolidated statement of comprehensive income in a single line, 'Share of gains/(losses) from associates and joint ventures'. There is no impact from the disposal on the alternatives net management fee margin, which is stated after excluding the joint venture AuM, and the effect of the disposal on the Group's profit before tax is immaterial.

Ashmore will announce its interim results in respect of the six months ended 31 December 2014 on 24 February 2015.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingAndrew Walton +44 (0)20 3727 1514Paul Marriott +44 (0)20 3727 1341

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTSFASMDFISELF
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.